Prices plus VAT plus shipping costs
Ready to ship today,
Delivery time appr. 5-8 days
- Order number: 7TM0105N
- Content: 100 µl
- Host: Rabbit
The non-phospho-GPR39 receptor antibody is directed against the distal end of the carboxyl-terminal tail of human GPR39. It can be used to detect total GPR39 receptors in Western blots independent of phosphorylation. The GPR39 antibody can also be used to isolate and enrich GPR39 receptors from tissue lysates. It also detects GPR39 in cultured cells and tissue sections by immunohistochemistry.
| Alternative Names | |
| IUPHAR Target ID | 105 |
| Uniprot ID | O43194 |
| Western Blot (WB) | 1:1000 |
| Immunohistochemistry (IHC) | 1:100 |
| Species Reactivity | Human |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Immunogen | A synthetic peptide corresponding to distal end of carboxy-terminal tail of human GPR39. |
| Form | Liquid |
| Purification | Antigen affinity chromatography |
| Storage buffer | Dulbecco's PBS, pH 7.4, with 150 mM NaCl, 0.02% sodium azide |
| Storage conditions | short-term 4°C, long-term -20°C |
Figure 1. Validation of the GPR39 Receptor in transfected HEK293 cells. Native HEK293 cells (MOCK) or HEK293 cells stably expressing the GPR39 Receptor (GPR39) were lysed and immunoblotted with the phosphorylation-independent anti-GPR39 antibody (7TM0105N) at a dilution of 1:1000.
Figure 2. Immunohistochemical identification of GPR39 Receptor in Kidney. Sections were dewaxed, microwaved in citric acid, and incubated with anti-GPR39 (GPR39 Receptor) antibody (7TM0105N) at a dilution of 1:100. Sections were then sequentially treated with biotinylated anti-rabbit IgG and avidin-biotin solution. Sections were then developed in 3,3-diaminobenzidine (DAB)-glucose oxidase and lightly counterstained with hematoxylin.
Figure 3. Immunohistochemical identification of GPR39 Receptor in Pancreas. Sections were dewaxed, microwaved in citric acid, and incubated with anti-GPR39 (GPR39 Receptor) antibody (7TM0105N) at a dilution of 1:100. Sections were then sequentially treated with biotinylated anti-rabbit IgG and avidin-biotin solution. Sections were then developed in 3,3-diaminobenzidine (DAB)-glucose oxidase and lightly counterstained with hematoxylin.
Figure 4. Immunohistochemical identification of GPR39 Receptor in Small Intestine. Sections were dewaxed, microwaved in citric acid, and incubated with anti-GPR39 (GPR39 Receptor) antibody (7TM0105N) at a dilution of 1:100. Sections were then sequentially treated with biotinylated anti-rabbit IgG and avidin-biotin solution. Sections were then developed in 3,3-diaminobenzidine (DAB)-glucose oxidase and lightly counterstained with hematoxylin.